Bal Pharma Ltd.

Financial

	Bal Pharma	Smruthi Organics	Tyche Inds
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.88 %	3.58 %	1.3 %
Financials
5 yr Average ROE	1.96 %	12.07 %	14.86 %
5yr average Equity Multiplier	4.59	1.54	1.18
5yr Average Asset Turnover Ratio	0.98	1.28	0.6
5yr Avg Net Profit Margin	-0.04 %	6.02 %	20.15 %
Price to Book	2.07	2.04	1.05
P/E	22.14	41.03	11.51
5yr Avg Cash Conversion Cycle	41.77 Days	70.37 Days	86.71 Days
Inventory Days	106.16 Days	63.4 Days	61.45 Days
Days Receivable	104.16 Days	105.63 Days	108.17 Days
Days Payable	132.37 Days	96.18 Days	93.08 Days
5yr Average Interest Coverage Ratio	1.22	10.52	2385.83
5yr Avg ROCE	15.4 %	16.62 %	19.65 %
5yr Avg Operating Profit Margin	7.79 %	12.47 %	23.57 %
5 yr average Debt to Equity	2.03	0.14	0.0
5yr CAGR Net Profit	n/a	-26.95 %	-6.96 %
5yr Average Return on Assets	0.43 %	8.16 %	12.43 %
Shareholdings
Promoter Holding	50.86 %	64.73 %	61.97 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.29 %	1.34 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Bal Pharma	Smruthi Organics	Tyche Inds
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 48.19 Formulations 45.98 0 Manufacture of bulk drugs intermediates 0 Others 5.83	Product Wise Break-Up Bulk Chemicals 100.0 Formulations 0 Active Pharmaceutical Ingredient (API) 0 Manufacture of bulk drugs intermediates 0	Product Wise Break-Up 0 Formulations 0 Active Pharmaceutical Ingredient (API) 0 Bulk Chemicals 100.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 64.15 India 35.85 International 0 Domestic 0	Location Wise Break-Up International 53.84 Rest of the World 0 Domestic 46.16 India 0	Location Wise Break-Up International 67.08 Rest of the World 0 Domestic 32.92 India 0